Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration. [electronic resource]
Producer: 20131031Description: 331-58 p. digitalISSN:- 1179-1969
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- economics
- Choroidal Neovascularization -- drug therapy
- Cost-Benefit Analysis
- Drug Administration Schedule
- Europe
- Humans
- Macular Degeneration -- drug therapy
- Multicenter Studies as Topic
- Randomized Controlled Trials as Topic
- Ranibizumab
- Treatment Outcome
- United States
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.